Telegram RegisterThe public register of Telegram
Telegram profile photo for Разработка и Регистрация ЛС | международный фарм.журнал

Channel

Разработка и Регистрация ЛС | международный фарм.журнал

@pharmjournal

On this record: Growth · Engagement · Reactions · Stars · Posts · Citations · Cite this entry

1,571subscribers

+1 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of 1,000–3,162.

Register entry

Telegram ID-1001541561148
TypeChannel
Username@pharmjournal
CreatedBetween 1 August 2021 and 28 February 2023— estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded7 August 2026
Last confirmed live27 August 2026
Measurements held7
Confirmed unchanged1 time, most recently 27 August 2026
On Telegramt.me/pharmjournal

Growth

1,5681,5721,5707 August 2026 — 1,570 subscribers7 August 2026 — 1,570 subscribers10 August 2026 — 1,568 subscribers14 August 2026 — 1,569 subscribers20 August 2026 — 1,572 subscribers24 August 2026 — 1,570 subscribers27 August 2026 — 1,571 subscribers1,5717 August 202627 August 2026
7 measurements spanning 20 days, net +1. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 1,567–1,573 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
27 Aug 2026, 20:581,571+1
24 Aug 2026, 20:061,570-2
20 Aug 2026, 19:231,572+3
14 Aug 2026, 01:291,569+1
10 Aug 2026, 19:231,568-2
7 Aug 2026, 23:001,570no change
7 Aug 2026, 22:581,570first reading

Engagement

20 posts held, back to 15 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.

ERR · 30 days
20.8%
avg views ÷ 1,571 subscribers
Avg views / post
327
5 posts measured
Reaction rate
1.89%
reactions ÷ views · ER floor
Posts in window
5
of 20 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views— note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 7 August 2026
Posts held20 (15 July 20267 August 2026)
Views total1,636
Reactions total31
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken7 Aug 2026, 23:00 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

155 reactions across 18 posts, in 12 distinct kinds. The most used accounts for 33.5% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👍5233.5%
❤‍🔥2717.4%
🔥2717.4%
1610.3%
🆒106.45%
💯63.87%
🥴63.87%
🍾31.94%
💊31.94%
🤔21.29%
🤝21.29%
🤓10.645%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 18 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 155reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 15 July 2026 to 7 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Telegram Stars

Stars received
5
across the posts below
Posts paid on
4
of 20 we hold a reading for · 20%
Most on one post
2
single highest reading

A paid reaction is a reader spending Telegram Stars — bought with money — on a post by @pharmjournal. Telegram publishes the count on the public post preview alongside ordinary reactions, and this register reads it there. It is the only figure on this site that measures money moving rather than attention.

Stars are not reactions, and the two are never added. They are rendered in the same strip on Telegram and counted in the same shape, but one is a tap and the other is a purchase. The reaction totals and the engagement rate elsewhere on this page exclude every figure in this section, and no rate here is computed against a reaction count.

This is not revenue, and we publish no currency figure. What a Star costs a reader and what it pays a channel are different numbers, Telegram takes a share we cannot observe, and the terms have changed. Converting a Star count into money would be an estimate dressed as a measurement, so the count is where we stop.

Counted over the 20 most recent posts we hold for this entry, published 15 July 2026 to 7 August 2026. Star counts above 1,000 reach us in Telegram’s short form and carry the same three-significant-figure rounding as everything else on this page.

Recent posts

7 Aug 2026, 09:08 UTC197 views2 reactionsread 7 August 2026
Photo

«АстраЗенека» в России подтвердила соответствие Стандартам общественного капитала бизнеса ✔️ Биофармацевтическая компания «АстраЗенека» в России по итогам оценки включена в реестр организаций, соответствующих Стандарту общественного капитала бизнеса. Реестр ведется на цифровой платформе АНО «Общественный капитал». ➡️ Стандарт общественного капитала бизнеса представляет собой единую национальную систему оценки вклад

👍2

4 Aug 2026, 13:14 UTC313 views5 reactionsread 7 August 2026
Photo

🟧ГЕРОФАРМ и ДВФУ совместно разработают инновационные препараты 🟧ГЕРОФАРМ и Дальневосточный федеральный университет (ДВФУ) подписали соглашение о долгосрочном сотрудничестве в области разработки новых лекарственных препаратов. Партнерство направлено на объединение индустриальной экспертизы компании и научных компетенций университета для создания новых перспективных лекарственных препаратов и их последующего вывода на

👍5

3 Aug 2026, 13:38 UTC338 views6 reactionsread 7 August 2026
Photo

🎓 Правильный ответ: изотополог (например, дейтерированное производное) аналита ❓ Почему? ➡️ Изотопологи (в частности, дейтерированные аналоги) считаются «золотым стандартом» в количественной биоаналитике. Их ключевое преимущество — практически идентичные физико-химические свойства с аналитом, что обеспечивает: 👌Ко-элюирование — изотополог выходит с тем же временем удерживания, что и аналит, и испытывает те же матр

💯3👍2🆒1

3 Aug 2026, 07:36 UTC330 views5 reactionsread 7 August 2026

Posted without readable text

2👍1🤝1🥴1

30 Jul 2026, 09:17 UTC458 views13 reactions1 Starread 7 August 2026
Photo

Следующий герой нашей рубрики «Компания в лицах» - Арчакова Ольга Александровна, к. фарм. н., заведующая лабораторией биоаналитических исследований ➡️ В Центре Фармацевтической Аналитики работает с 2018 года. За это время прошла путь от лаборанта-исследователя до одного из ведущих сотрудников компании. С 2023 года является заведующей лабораторией биоаналитических исследований. 🎓 В 2024 году успешно защитила диссерт

❤‍🔥7🥴2🆒21🍾1

28 Jul 2026, 10:08 UTC378 views14 reactionsread 7 August 2026
Photo

Новый цикл рубрики «Компания в лицах» открывает наш стажер Анастасия Орлова. 1️⃣ Вопрос 1. Какое открытие о себе или о профессии ты сделал здесь уже выйдя за рамки привычного «я это умею»? 💙 Ответ: Начнем с того, что когда я пришла в качестве стажера в ЦФА, я была абсолютно не знакома с миром фармацевтики и клинических исследований. Я очень благодарна команде, что в меня поверили и дали мне возможность поучаствоват

🔥8👍3🆒2🤔1

27 Jul 2026, 13:52 UTC331 views4 reactionsread 7 August 2026
Photo

🎓Правильный ответ: GLP-1 и GIP ❓ Почему? ➡️ Тирзепатид — это первый представитель нового класса препаратов, который является двойным агонистом рецепторов GIP и GLP-1. В отличие от селективных агонистов GLP-1 (например, семаглутида или лираглутида), тирзепатид одновременно активирует оба рецептора, что и обеспечивает его уникальный профиль эффективности. 📌Поэтому для корректной оценки специфической фармакологическо

👍2💯1🆒1

23 Jul 2026, 13:44 UTC452 views2 reactionsread 7 August 2026
Photo

✔️ Применение эфзимфотазы альфа привело к улучшению состояния костной ткани у детей с гипофосфатазией, ранее не получавших лечения ➡️ В клиническом исследовании III фазы MULBERRY при применении эфзимфотазы альфа было достигнуто улучшение по вторичным конечным точкам, характеризующим функциональный статус и качество жизни 📌 В масштабной программе клинических исследований III фазы при ГФФ, включающей в себя исследова

👍2

23 Jul 2026, 09:13 UTC344 views19 reactions2 Starsread 7 August 2026
Photo

🔔 Следующий герой нашей рубрики «Компания в лицах» - Комаров Тимофей Николаевич, д.фарм. н, директор исследовательского центра. ➡️ В «Центре Фармацевтической Аналитики» работает с 2015 года. За это время работал в должности старшего химика-аналитика, заведующего лабораторией биоаналитических исследований № 2. С 2023 года является директором исследовательского центра. 1️⃣ Вопрос 1: Какое открытие о себе или о профес

👍94🥴3🔥1🤔1🆒1

21 Jul 2026, 11:48 UTC347 views20 reactions1 Starread 7 August 2026
Photo

✔️ Новый цикл рубрики «Компания в лицах» мы посвятим мужской части нашего коллектива ООО «ЦФА». 📌 Шохин Игорь Евгеньевич - д.фарм.н., генеральный директор ООО «ЦФА». Главный редактор научно-производственного журнала «Разработка и регистрация лекарственных средств». Эксперт Российского научного фонда, бессменный председатель организационного комитета цикла конференций «Разработка и регистрация лекарственных средств».

🔥7❤‍🔥43👍3🍾2💊1

21 Jul 2026, 08:05 UTC324 views8 reactionsread 7 August 2026
Photo

🟧 Семавик укрепил лидерство на рынке семаглутидов Узбекистана 🟧Семавик занял лидирующую позицию на рынке препаратов сегмента в Узбекистане. Препарат вышел на рынок страны в конце прошлого года. По данным IQVIA, с декабря 2025 года по март 2026 года его доля в денежном выражении на рынке семаглутидов составила 55,8%. 🟧Согласно отчету Всемирной организации здравоохранения, в Узбекистане ожирением страдает почти кажды

👍4❤‍🔥2🔥2

Showing the 12 most recent of 20 posts we hold for @pharmjournal. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Stars beside a post are paid reactions — Telegram Stars, bought with money and spent on that post. They are a different unit from reactions and are never added to them, here or anywhere else on this page.

Citation-graph rank

Citation-graph rank — 546,581 of 1,621,754entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 27 August 2026 — this entry's latest reading, not the date you are reading this.

“Разработка и Регистрация ЛС | международный фарм.журнал” (@pharmjournal), 1,571 subscribers as measured 27 August 2026. Telegram Register, tgregister.com/channel/pharmjournal.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.